Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Foreign investors buy UK firms at fastest pace since 2007

Tue, 24th Mar 2015 15:02

* UK acquisitions by foreign buyers total $48 bln year todate

* Highest since 2007 even if bid for O2 is excluded

* Weaker pound, better growth lure U.S. buyers

* Political uncertainty fails to dampen appetite

By Francesco Canepa

LONDON, March 24 (Reuters) - Foreign investors are snappingup British companies at the fastest pace in eight years as anunusual combination of stronger economic growth and a weakcurrency lures U.S. buyers despite political uncertainty.

Investors appear relatively unconcerned about the risk ofinstability after a general election on May 7 or doubts aboutBritain's future in the European Union. Even excluding a $15billion bid by Hutchison Whampoa for O2's UKoperations, inbound mergers & acquisitions activity so far thisyear is at its highest since 2007, Thomson Reuters data showed.

The total value of bids and completed deals in the period is$33 billion, including debt taken on by buyers. The figure risesto $48 billion when Hong Kong-based Hutchison's bid for themobile phone operator is included.

This reverses a seven-year decline and contrasts to a fallin inbound M&A activity in the euro zone and United States.

It also confounds expectations of dwindling M&A before theelections, in which opinion polls suggest no party will win amajority. This raises the possibility of an unstable coalitionor minority government propped up by smaller parties such as thepro-independence Scottish nationalists.

On top of this, the ruling Conservatives have promised areferendum within two years on whether Britain should leave theEU, should they be re-elected.

Many British business leaders are worried by the prospect.The chairman of insurer Standard Life said on Tuesday it would be disastrous for the country and London's financialcentre if Britain were to leave the EU single market.

However, bankers say U.S. investors are being attracted bysterling's weakness against the dollar - which makes Britishtargets cheaper for them - even though the economy is buoyant.

"The UK is at the forefront because the economy, aside fromthe uncertainty around the elections, is an attractive marketwith good growth dynamics," said Dirk Albersmeier, co-head ofM&A for Europe, the Middle East and Africa at JP Morgan.

With the Bank of England expected to keep interest ratesultra low for another year, the pound has fallen 13 percentagainst the dollar since July and is now hovering just above afive-year low. At the same time, official economic growthforecasts were upgraded last week to 2.5 percent this year and2.3 percent in 2016.

VALUATIONS BOOST

Valuations have provided a further boost. UK shares trade ata 10 percent discount to their U.S. counterparts based on theratio between price and expected earnings, Datastream datashowed.

Inbound M&A activity in Britain had been falling since 2007,data from the Office for National Statistics showed, partly dueto the pound's recovery against the euro since 2009.

This year's increase has been driven by 73 small andmid-sized acquisitions by U.S. buyers, such as drinks can makerBall Corp's $8.6 billion move for rival Rexam and a $2.8 billion bid by Verisk Analytics for energyconsultancy Wood Mackenzie.

These deals have more than offset a drying up of last year'sstream of large bids which were partly motivated by lowercorporate tax rates in Britain than in the United States, suchas Pfizer's abandoned attempt to buy fellowpharmaceutical group AstraZeneca.

Such bids have been curbed by a tightening of U.S. tax rulesand worries about possible fiscal changes in Britain after theelections.

As the economic recovery picks up pace, sectors which dependon growth are playing a larger role in M&A, joining defensivesectors such as healthcare and telecommunications, media andtechnology (TMT), where activity has been high for some time.

Aside from the telecoms and materials sectors, where theamount was skewed by the O2 and Rexam bids, inbound M&A activitythis year has been at its highest in the consumer goods sectorand industrial sectors, the data showed.

This marks a change from the previous year, when real estatedominated, with financials and high tech a distant second andthird, respectively.

"Activity is likely to be more broad-based than last year,"said Wilhelm Schulz, head of M&A for Europe, the Middle East andAfrica at Citi. "I expect this year we will see activity inhealthcare, TMT, industrials, chemicals and consumer products." (Additional reporting by Anjuli Davies and Freya Berry; editingby David Stamp)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.